Skip to main navigation Skip to search Skip to main content

Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalActa Oncologica
Volume65
Pages (from-to)131-140
Number of pages10
ISSN0284-186X
DOIs
Publication statusPublished - 19 Feb 2026
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Adverse effects
  • Effectiveness
  • Neoadjuvant therapy
  • Pembrolizumab
  • Real-world evidence
  • Triple-negative breast cancer
  • 3122 Cancers

Cite this